Showing results (1831-1840 of 1,974) with videos related to

Sort By:
Pageof 198
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 23, 2021
Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal CancerLinda X Yin, Emily E Karp, Anna Elias, et al.
The Lancet. Oncology|May 1, 2020
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trialSara M Tolaney, Andrew M Wardley, Stefania Zambelli, et al.
Circulation|November 23, 2022
Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion RemodelingAlberto Canfrán-Duque, Noemi Rotllan, Xinbo Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Nrf2 mediates cancer protection but not prolongevity induced by caloric restrictionKevin J Pearson, Kaitlyn N Lewis, Nathan L Price, et al.
Genome Biology|January 23, 2025
Dynamic co-evolution of transposable elements and the piRNA pathway in African cichlid fishesMiguel Vasconcelos Almeida, Moritz Blumer, Chengwei Ulrika Yuan, et al.
The Laryngoscope|July 19, 2022
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell CarcinomaEmily E Karp, Linda X Yin, Thomas Jamie O'Byrne, et al.
American Journal of Otolaryngology|September 11, 2021
The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective reviewEmily E Karp, Joaquin J Garcia, Stephen A Chan, et al.
JCI Insight|October 16, 2019
Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosisNathan L Price, Verónica Miguel, Wen Ding, et al.
Elife|April 20, 2021
A cross-sectional study of functional and metabolic changes during aging through the lifespan in male miceMichael A Petr, Irene Alfaras, Melissa Krawcyzk, et al.
JCI Insight|August 27, 2024
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progressionPablo Fernández-Tussy, Magdalena P Cardelo, Hanming Zhang, et al.
Pageof 198